Comments on: Takeda to divest dry eye drug to Novartis in $5.3bn deal

Comments on: Takeda to divest dry eye drug to Novartis in $5.3bn deal /news/takeda-novartis-xiidra-deal/ The leading site for news and procurement in the pharmaceutical industry Thu, 09 May 2019 09:39:57 +0000 hourly 1 https://wordpress.org/?v=6.6.2